- Ticker iNav Bloomberg: IV3ELEUR
- Exchange ticker: V3EL
- Bloomberg: V3EL IM
- ISIN: IE000NRGX9M3
- MEX ID: VRAACE
- Reuters: V3EL.MI
- SEDOL: BPNZVH0
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
As at 30 lis 2025
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 989 | 971 | 30 lis 2025 |
| Median market capital | 49,5 B | 49,5 B | 30 lis 2025 |
| 16,5 x | 16,6 x | 30 lis 2025 | |
| 2,2 x | 2,2 x | 30 lis 2025 | |
| 13,1% | 13,1% | 30 lis 2025 | |
| 13,6% | 13,6% | 30 lis 2025 | |
| Portfolio turnover rate | 3,0% | — | 30 wrz 2025 |
As at 30 lis 2025
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| Wielka Brytania | Europa | 19,70% | 19,73% | -0,03% |
| Szwajcaria | Europa | 16,58% | 16,61% | -0,03% |
| Niemcy | Europa | 15,19% | 15,08% | 0,11% |
| Francja | Europa | 9,85% | 10,35% | -0,50% |
| Holandia | Europa | 8,97% | 8,98% | -0,01% |
| Szwecja | Europa | 6,89% | 6,90% | -0,01% |
| Hiszpania | Europa | 5,48% | 5,49% | -0,01% |
| Włochy | Europa | 5,31% | 5,31% | 0,00% |
| Dania | Europa | 3,91% | 3,91% | 0,00% |
| Belgia | Europa | 2,02% | 2,03% | -0,01% |
| Finlandia | Europa | 1,82% | 1,83% | -0,01% |
| Norwegia | Europa | 1,17% | 1,17% | 0,00% |
| Polska | Europa | 0,98% | 0,98% | 0,00% |
| Irlandia | Europa | 0,73% | 0,73% | 0,00% |
| Austria | Europa | 0,67% | 0,67% | 0,00% |
As at 30 lis 2025
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 3,95402% | Technology | NL | 7 161 251,80 € | 7927 |
| AstraZeneca PLC | 2,65906% | Health Care | GB | 4 815 909,43 € | 30 186 |
| Roche Holding AG | 2,57908% | Health Care | CH | 4 671 052,49 € | 14 160 |
| Nestle SA | 2,41009% | Consumer Staples | CH | 4 364 992,68 € | 50 953 |
| SAP SE | 2,38416% | Technology | DE | 4 318 027,75 € | 20 705 |
| Novartis AG | 2,32821% | Health Care | CH | 4 216 698,81 € | 37 609 |
| Siemens AG | 1,86408% | Industrials | DE | 3 376 100,40 € | 14 788 |
| Allianz SE | 1,59907% | Financials | DE | 2 896 121,70 € | 7779 |
| Banco Santander SA | 1,52416% | Financials | ES | 2 760 449,68 € | 298 653 |
| Novo Nordisk A/S | 1,50391% | Health Care | DK | 2 723 781,17 € | 64 174 |
-
Inception date
16 sie 2022
Listing date
18 sie 2022
| Date | NAV (EUR) | Market price (EUR) |
|---|---|---|
| 31 gru 2025 | 6,5010 € | — |
| 30 gru 2025 | 6,5079 € | 6,5140 € |
| 29 gru 2025 | 6,4728 € | 6,4760 € |
| 26 gru 2025 | 6,4623 € | — |
| 24 gru 2025 | 6,4618 € | — |
| 23 gru 2025 | 6,4623 € | 6,4640 € |
| 22 gru 2025 | 6,4385 € | 6,4410 € |
| 19 gru 2025 | 6,4446 € | 6,4490 € |
| 18 gru 2025 | 6,4260 € | 6,4240 € |
| 17 gru 2025 | 6,3867 € | 6,3850 € |
Distribution frequency
Quarterly
Historical performance 30 lis 2025
2,74%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | 0,0208 € | 18 gru 2025 | 19 gru 2025 | 31 gru 2025 |
| Income | 0,0168 € | 18 wrz 2025 | 19 wrz 2025 | 01 paź 2025 |
| Income | 0,1161 € | 19 cze 2025 | 20 cze 2025 | 02 lip 2025 |
| Income | 0,0204 € | 20 mar 2025 | 21 mar 2025 | 02 kwi 2025 |
| Income | 0,0197 € | 12 gru 2024 | 13 gru 2024 | 27 gru 2024 |
| Income | 0,0183 € | 12 wrz 2024 | 13 wrz 2024 | 25 wrz 2024 |
| Income | 0,1055 € | 13 cze 2024 | 14 cze 2024 | 26 cze 2024 |
| Income | 0,0176 € | 14 mar 2024 | 15 mar 2024 | 27 mar 2024 |
| Income | 0,0159 € | 14 gru 2023 | 15 gru 2023 | 27 gru 2023 |
| Income | 0,0169 € | 14 wrz 2023 | 15 wrz 2023 | 27 wrz 2023 |
Listed currencies: EUR, GBP
Base currency: EUR
Exchanges: NYSE Euronext - Amsterdam, London Stock Exchange, Deutsche Boerse, Borsa Italiana S.p.A.